KANABO GROUP PLC  5

KANABO GROUP PLC 5 Share · GB00BYQCS703 · A2DRUH (XLON) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of KANABO GROUP PLC 5
No Price
Share Float & Liquidity
Free Float 58,19 %
Shares Float 368,02 M
Shares Outstanding 632,43 M
Company Profile for KANABO GROUP PLC 5 Share
Kanabo Group Plc develops and distributes cannabis-derived products for medical patients. It also offers non- tetrahydrocannabinol products for cannabidiol consumers. The company offers its products under the Kanabo brand name. Kanabo Group Plc was founded in 2016 and is based in London, the United Kingdom. Kanabo Group Plc is a subsidiary of Altshuler Shaham Trusts Ltd.

Company Data

Name KANABO GROUP PLC 5
Company Kanabo Group Plc
Website https://www.kanabogroup.com
Primary Exchange XLON London
WKN A2DRUH
ISIN GB00BYQCS703
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Avihu Tamir
Country United Kingdom
Currency GBP
Employees 0,0 T
Address Churchill House, NW4 4DJ London
IPO Date 2017-05-17

Ticker Symbols

Name Symbol
Frankfurt 3WD.F
London KNB.L
London SOP.L
More Shares
Investors who hold KANABO GROUP PLC 5 also have the following shares in their portfolio:
Village Vanguard CO.,LTD.
Village Vanguard CO.,LTD. Share
WRTS LKD A SHS TBEA CO LTD 12/12/2022
WRTS LKD A SHS TBEA CO LTD 12/12/2022 Verbriefte Derivate